Highbridge Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Highbridge Capital Management's RARE Position: Q2 2018 in Review
Highbridge Capital Management sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2018, closing a stake of 30,000 shares — an estimated $1.53M sold.
Highbridge Capital Management first reported a position in RARE in Q4 2014 and held it in 4 quarters. The position peaked at $2.13M in Q1 2015. 158 funds tracked by Wall St. Rank hold RARE as of Q2 2018.
- Highbridge Capital Management reported no remaining Ultragenyx Pharmaceutical position as of Q2 2018 after selling out during the quarter.
- Highbridge Capital Management sold 30,000 Ultragenyx Pharmaceutical shares in Q2 2018, an estimated $1.53M.
- Highbridge Capital Management first reported a position in Ultragenyx Pharmaceutical in Q4 2014 and held it in 4 quarters.
- Highbridge Capital Management's Ultragenyx Pharmaceutical position peaked at $2.13M in Q1 2015.
- 158 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2018.
Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.